Applied Genetic Technologies Corporation Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares

Published: Apr 04, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

GAINESVILLE, Fla., April 3, 2014 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC) announced today the closing on April 1, 2014 of its initial public offering of 4,166,667 shares of its common stock at an initial public offering price of $12.00 per share, and the exercise in full by the underwriters of their option to purchase 625,000 additional shares of common stock, which closed on April 3, 2014. AGTC offered all of the shares of common stock. The aggregate net proceeds to AGTC, after underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $51.8 million.

Help employers find you! Check out all the jobs and post your resume.

Back to news